Effect of Vitamin D on Glucose Homeostasis, Sensitivity and Insulin Resistance in Type 2 Diabetes

 

Abstract

Background: In recent years, non-bone diseases have been reported with vitamin D deficiency, one of them is type 2 diabetes, which is a group of metabolic disorders caused by insulin action deficiency. Evidences suggest that vitamin D deficiency affects the metabolic function of cells, including beta-pancreatic cells. Regarding the fact that some studies have shown the effect of vitamin D on control of type 2 diabetes, the present study aims to review on the relationship between vitamin D, glucose homeostasis and insulin resistance type 2 diabetes.

Methods: This study is a review on descriptive and analytic studies which accessed data using biochemical tests, questionnaires and interviews. By using key words on vitamin D, type 2 diabetes and insulin resistance, 10 articles including descriptive-analytic, cross-sectional, case-control and interventional types from 1986 to 2018 were conducted.

Results: Many studies have shown that vitamin D levels of 25-hydroxyvitamin D in diabetics, women, and obese people are lower than others. It shows the effect of vitamin D on glucose homeostasis. In addition, vitamin D has an effect on intracellular calcium therefore it influences on insulin secretion. It can be said that vitamin D deficiency causes calcium inefficiency to regulate insulin secretion.

Conclusion: According to studies, it can be concluded that vitamin D might be effective in preventing type 2 diabetes and its controlling. Also, there is no association between vitamin D and insulin secreted by food and hemoglobin A1c (HbA1c). 

 

Read More About This Article:https://juniperpublishers.com/crdoj/CRDOJ.MS.ID.555810.php

Read More Juniper Publishers Google Scholar Articles:  https://scholar.google.com/citations?view_op=view_citation&hl=en&user=KKJjfyEAAAAJ&citation_for_view=KKJjfyEAAAAJ:WIXB4To3Tx4C

 

Comments

Post a Comment

Popular posts from this blog

Studies on Glucagon Receptor and Antagonists of Glucagon Receptor for the Management of Diabetes Mellitus

Image
  CURRENT RESEARCH IN DIABETES & OBESITY JOURNAL   JUNIPER PUBLISHERS Authored by Ghulam Abbas Abstract Glucagon receptor plays an important role in the glucose homeostasis and thus is drug target for the management of hyperglycemia in type-2 diabetes mellitus. The suppression of glucagon secretion from the alpha-cells is the key to control hyperglycemic condition. The identification of non-peptide antagonists of glucagon receptor is an effective therapeutic approach to inhibit the glucagon secretion to achieve normal glucose index. Keywords:  Glucagon receptor; Hyperglycemia; Diabetes mellitus; Antagonists Go to Introduction Background Diabetes mellitus is a chronic metabolic disorder which is spreading at an alarming rate all over the world. Glucagon receptor belongs to the G protein-coupled receptors (GPCRs) superfamily and an important drug target for type-2 diabetes [1]. G-Proteins (guanine nucleotide binding proteins) actually act as molecular switches to turn o...
Read more

How Juniper Publishers Promotes Open Science

Juniper Publishers plays a pivotal role in advancing open science by fostering accessibility, transparency, and collaboration within the global research community. Their commitment to open science is reflected through various initiatives that remove barriers to knowledge and promote the dissemination of research findings.   1. Open Access Journals One of the primary ways Juniper Publishers promotes open science is through its open-access publishing model. By offering free and unrestricted access to scientific research articles, they ensure that anyone, regardless of their location or financial resources, can access valuable scientific knowledge. This open-access approach dismantles the paywall barriers typically associated with traditional publishing, thus making research accessible to a wider audience, including researchers, students, policymakers, and the general public. 2. Encouraging Collaboration and Networking Juniper Publishers fosters an environment that encourages coll...
Read more

Is Juniper Publishers Legit in 2025? A Transparent Review for Researchers

  In 2025, the academic publishing landscape continues to evolve rapidly. With the rise of open-access publishing, researchers now have more opportunities than ever to share their findings globally. Among the publishers frequently discussed in this space is Juniper Publishers — often associated with accessibility, faster publication timelines, and international reach. But an important question many researchers ask is: Is Juniper Publishers legitimate in 2025? This transparent review examines what the publisher offers, what researchers typically look for, and whether it may align with your academic publishing goals. Juniper Publishers in 2025: An Overview As of 2025, Juniper Publishers remains an active open-access academic publisher serving researchers across scientific, medical, and interdisciplinary fields. Many authors choose Juniper for several practical reasons, including: Faster editorial and peer-review timelines A user-friendly manuscript subm...
Read more